Dr. Yixing Jiang, MD, PhD
Claim this profileUniversity of Maryland/Greenebaum Cancer Center
Area of expertise
Cancer
Yixing Jiang, MD, PhD has run 3 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Yixing Jiang, MD, PhD has run 3 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
University Of Maryland/Greenebaum Cancer Center
University Of Maryland Comprehensive Cancer Center
Clinical Trials Yixing Jiang, MD, PhD is currently running
CPI-0209
for Cancer and Lymphoma
The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.
Recruiting
1 award
Phase 1 & 2
8 criteria
Durvalumab + Chemotherapy
for Bile Duct Cancer
This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving durvalumab with gemcitabine and cisplatin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed in patients with high risk resectable cholangiocarcinoma.
Recruiting
1 award
Phase 2
More about Yixing Jiang, MD, PhD
Clinical Trial Related
8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Yixing Jiang, MD, PhD has experience with
- Gemcitabine
- Galeterone
- CPI-0209
- NovoTTF-200T
- NovoTTF-100L(P)
- Nab Paclitaxel
Breakdown of trials Yixing Jiang, MD, PhD has run
Cancer
Solid Tumors
Liver Cancer
Pancreatic Cancer
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yixing Jiang, MD, PhD specialize in?
Yixing Jiang, MD, PhD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Yixing Jiang, MD, PhD currently recruiting for clinical trials?
Yes, Yixing Jiang, MD, PhD is currently recruiting for 2 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Yixing Jiang, MD, PhD has studied deeply?
Yes, Yixing Jiang, MD, PhD has studied treatments such as Gemcitabine, Galeterone, CPI-0209.
What is the best way to schedule an appointment with Yixing Jiang, MD, PhD?
Apply for one of the trials that Yixing Jiang, MD, PhD is conducting.
What is the office address of Yixing Jiang, MD, PhD?
The office of Yixing Jiang, MD, PhD is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.